You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts
McKinsey
McKesson
Boehringer Ingelheim
Medtronic
Baxter

Last Updated: May 18, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR TAZAROTENE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Tazarotene

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00145106 Comparison of Tazarotene and Minocycline Therapies for Maintenance of Facial Acne Vulgaris Completed Allergan Phase 4 2002-03-01 The purpose of the study is to compare the efficacy of three maintenance regimens (topical tazarotene, oral minocycline, or both) in sustaining improvement in acne.
NCT00145106 Comparison of Tazarotene and Minocycline Therapies for Maintenance of Facial Acne Vulgaris Completed Jefferson Medical College of Thomas Jefferson University Phase 4 2002-03-01 The purpose of the study is to compare the efficacy of three maintenance regimens (topical tazarotene, oral minocycline, or both) in sustaining improvement in acne.
NCT00145106 Comparison of Tazarotene and Minocycline Therapies for Maintenance of Facial Acne Vulgaris Completed Milton S. Hershey Medical Center Phase 4 2002-03-01 The purpose of the study is to compare the efficacy of three maintenance regimens (topical tazarotene, oral minocycline, or both) in sustaining improvement in acne.
NCT00145106 Comparison of Tazarotene and Minocycline Therapies for Maintenance of Facial Acne Vulgaris Completed New York University School of Medicine Phase 4 2002-03-01 The purpose of the study is to compare the efficacy of three maintenance regimens (topical tazarotene, oral minocycline, or both) in sustaining improvement in acne.
NCT00145106 Comparison of Tazarotene and Minocycline Therapies for Maintenance of Facial Acne Vulgaris Completed State University of New York - Downstate Medical Center Phase 4 2002-03-01 The purpose of the study is to compare the efficacy of three maintenance regimens (topical tazarotene, oral minocycline, or both) in sustaining improvement in acne.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Tazarotene

Condition Name

Condition Name for Tazarotene
Intervention Trials
Acne Vulgaris 20
Plaque Psoriasis 5
Psoriasis 2
Nail Psoriasis 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Tazarotene
Intervention Trials
Acne Vulgaris 20
Psoriasis 10
Basal Cell Nevus Syndrome 2
Carcinoma 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Tazarotene

Trials by Country

Trials by Country for Tazarotene
Location Trials
United States 115
Canada 6
India 2
Belize 1
Germany 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Tazarotene
Location Trials
California 11
Florida 10
Texas 8
Pennsylvania 8
New York 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Tazarotene

Clinical Trial Phase

Clinical Trial Phase for Tazarotene
Clinical Trial Phase Trials
Phase 4 9
Phase 3 8
Phase 2 12
[disabled in preview] 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Tazarotene
Clinical Trial Phase Trials
Completed 24
Recruiting 6
Not yet recruiting 4
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Tazarotene

Sponsor Name

Sponsor Name for Tazarotene
Sponsor Trials
Stiefel, a GSK Company 8
GlaxoSmithKline 8
Allergan 4
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Tazarotene
Sponsor Trials
Industry 40
Other 23
NIH 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Moodys
Express Scripts
Dow
McKesson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.